Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Incedit Biotechnology is a specialized pharmaceutical company based in China that focuses on the development and manufacture of high-value active pharmaceutical ingredients (APIs) and complex intermediates. The company is particularly recognized for its expertise in the synthesis of Vitamin D derivatives and prostaglandin analogues, which require sophisticated multi-step chemical processes. Their product portfolio includes key treatments for bone metabolism disorders, dermatological conditions, and ophthalmic diseases, such as Calcitriol, Calcipotriol, and Latanoprost. Xi'an Incedit operates research and manufacturing facilities that comply with international quality standards, enabling them to serve as a reliable partner for global pharmaceutical firms. In addition to catalog products, the company offers custom synthesis and CDMO services tailored to specific client requirements. By integrating advanced R&D with scalable production, Xi'an Incedit Biotechnology supports the global supply chain for critical specialty medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Incedit Bio-Tech.